Oxilofrine

Oxilofrine
Clinical data
ATC code	none;
Legal status
Legal status	BR: Class A3 (Psychoactive drugs); US: Unapproved "New Drug" (as defined by 21 U.S. Code § 321(p)(1)). Use in dietary supplements, food, or medicine is unlawful; otherwise uncontrolled.;
Identifiers
	IUPAC name (1S,2R)-(±)-4-(1-Hydroxy-2-methylamino-propyl)phenol;
CAS Number	365-26-4 ;
PubChem CID	9701;
DrugBank	DB11610 ;
ChemSpider	9320 ;
UNII	F49638UBDR;
KEGG	D08314 ;
ChEMBL	ChEMBL30400 ;
CompTox Dashboard (EPA)	DTXSID30110025 ;
ECHA InfoCard	100.006.067
Chemical and physical data
Formula	C10H15NO2
Molar mass	181.235 g·mol−1
	InChI InChI=1S/C10H15NO2/c1-7(11-2)10(13)8-3-5-9(12)6-4-8/h3-7,10-13H,1-2H3 ; Key:OXFGTKPPFSCSMA-UHFFFAOYSA-N ;
	(what is this?) (verify)

Oxilofrine (also known as methylsynephrine, hydroxyephrine, oxyephrine, and 4-HMP) is a substituted phenethylamine stimulant drug chemically related to ephedrine and to synephrine.

Oxilofrine is currently a World Anti-Doping Agency (WADA) prohibited substance when used in competition. It has been found as an adulterant in some dietary supplements. Even after receiving warning letters from the FDA, some sports and weight loss supplement companies continue to use oxilofrine as an undeclared ingredient in their products despite it being prohibited.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.